Literature DB >> 7523136

Inhibition of nitric oxide synthesis by interleukin-4 may involve inhibiting the activation of protein kinase C epsilon.

W A Sands1, V Bulut, A Severn, D Xu, F Y Liew.   

Abstract

The murine macrophage cell line, J774, when activated with interferon-gamma (IFN-gamma), expressed high level of inducible nitric oxide synthase (iNOS) and bound significantly more [3H]-phorbol-dibutyrate (PBu2) compared to non-activated cells. The increased PBu2 binding to the particulate fraction of the cells is a measure of activation and translocation of protein kinase C (PKC). Both the expression of iNOS and the enhanced. PBU2 binding in the activated J774 cells were significantly inhibited by the pretreatment of the cells with murine recombinant interleukin-4 (IL-4). Stimulation of J774 cells by IFN-gamma and lipopolysaccharide results in the translocation predominantly of the epsilon isoform of PKC (PKC-epsilon), and this is inhibited by IL-4. The inhibition of PKC activation was also evident by measuring the PKC activity in the cytosolic-fraction of the IL-4-treated cells. Activated J774 cells pretreated with IL-4 or a PKC-specific inhibitor (RO31-8220) failed to express mRNA of iNOS analyzed by PCR. These results, therefore, suggest that the inhibition of nitric oxide synthesis in activated murine macrophages by IL-4 is at the transcriptional level and may involve the inhibition of the activation of PKC-epsilon.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523136     DOI: 10.1002/eji.1830241013

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

Review 1.  Emerging and diverse roles of protein kinase C in immune cell signalling.

Authors:  Seng-Lai Tan; Peter J Parker
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

2.  Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators.

Authors:  F H Guo; K Uetani; S J Haque; B R Williams; R A Dweik; F B Thunnissen; W Calhoun; S C Erzurum
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

3.  Nitric oxide regulates clonal expansion and activation-induced cell death triggered by staphylococcal enterotoxin B.

Authors:  A Brás; L Rodríguez-Borlado; A González-Garcia; C Martínez-A
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  Xanthoceraside attenuates amyloid β peptide₂₅₋₃₅-induced learning and memory impairments in mice.

Authors:  Ping Lu; Takayoshi Mamiya; Lingling Lu; Akihiro Mouri; Takashi Ikejima; Hyoung-Chum Kim; Li-Bo Zou; Toshitaka Nabeshima
Journal:  Psychopharmacology (Berl)       Date:  2011-07-07       Impact factor: 4.530

5.  Central role for interleukin-4 in regulating nitric oxide-mediated inhibition of T-cell proliferation and gamma interferon production in schistosomiasis.

Authors:  Elisabeth A Patton; Anne C La Flamme; Joao A Pedras-Vasoncelos; Edward J Pearce
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

6.  AChE and RACK1 promote the anti-inflammatory properties of fluoxetine.

Authors:  Nir Waiskopf; Keren Ofek; Adi Gilboa-Geffen; Uriya Bekenstein; Assaf Bahat; Estelle R Bennett; Erez Podoly; Oded Livnah; Gunther Hartmann; Hermona Soreq
Journal:  J Mol Neurosci       Date:  2013-11-21       Impact factor: 3.444

7.  Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease.

Authors:  C M Hogaboam; B A Vallance; A Kumar; C L Addison; F L Graham; J Gauldie; S M Collins
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

8.  Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.

Authors:  Diethilde J Theil; Jane E Libbey; Fernando Rodriguez; J Lindsay Whitton; Ikuo Tsunoda; Tobias J Derfuss; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2008-11-15       Impact factor: 3.478

9.  Helminth antigen-based strategy to ameliorate inflammation in an experimental model of colitis.

Authors:  Y Motomura; H Wang; Y Deng; R T El-Sharkawy; E F Verdu; W I Khan
Journal:  Clin Exp Immunol       Date:  2008-11-06       Impact factor: 4.330

Review 10.  Graft-versus-host disease and the Th1/Th2 paradigm.

Authors:  W Krenger; J L Ferrara
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.